NDC 64679-636 Octreotide Acetate
View Dosage, Usage, Ingredients, Routes, UNII
Product Information
- 64679 - Wockhardt Usa Llc.
- 64679-636 - Octreotide Acetate
Product Packages
NDC Code 64679-636-01
Package Description: 1 VIAL in 1 CARTON / 1 mL in 1 VIAL
NDC Code 64679-636-02
Package Description: 10 VIAL in 1 CARTON / 1 mL in 1 VIAL
Product Details
What is NDC 64679-636?
What are the uses for Octreotide Acetate?
Which are Octreotide Acetate UNII Codes?
The UNII codes for the active ingredients in this product are:
- OCTREOTIDE ACETATE (UNII: 75R0U2568I)
- OCTREOTIDE (UNII: RWM8CCW8GP) (Active Moiety)
Which are Octreotide Acetate Inactive Ingredients UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- ACETIC ACID (UNII: Q40Q9N063P)
- SODIUM ACETATE (UNII: 4550K0SC9B)
- SODIUM CHLORIDE (UNII: 451W47IQ8X)
- WATER (UNII: 059QF0KO0R)
What is the NDC to RxNorm Crosswalk for Octreotide Acetate?
- RxCUI: 312068 - octreotide 50 MCG in 1 ML Injection
- RxCUI: 312068 - 1 ML octreotide 0.05 MG/ML Injection
- RxCUI: 312068 - octreotide 50 MCG per 1 ML Injection
- RxCUI: 312069 - octreotide 100 MCG in 1 ML Injection
- RxCUI: 312069 - 1 ML octreotide 0.1 MG/ML Injection
* Please review the disclaimer below.
Patient Education
Octreotide Injection
Octreotide immediate-release injection is used to decrease the amount of growth hormone (a natural substance) produced by people with acromegaly (condition in which the body produces too much growth hormone, causing enlargement of the hands, feet, and facial features; joint pain; and other symptoms) who cannot be treated with surgery, radiation, or another medication. Octreotide immediate-release injection is also used to control diarrhea and flushing caused by carcinoid tumors (slow-growing tumors that release natural substances that can cause symptoms) and vasoactive intestinal peptide secreting adenomas (VIP-omas; tumors that form in the pancreas and release natural substances that can cause symptoms). Octreotide long-acting injection is used to control acromegaly, carcinoid tumors, and VIP-omas in people who have been successfully treated with octreotide injection but prefer to receive injections less often. Octreotide injection is in a class of medications called octapeptides. It works by decreasing the amounts of certain natural substances produced by the body.
[Learn More]
* Please review the disclaimer below.
[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.
[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.
[11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.
[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".